ArticleBlood2011

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.

Wei Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.